Our Core Research Team
We are twelve independent laboratories working together to find new ways to prevent cancers, better treat cancers and understand how they arise.
DNA Damage & Repair Researchers
Cellular Aging Researchers
Dr. Ebba Kurz
Short Bio Summary
Dr. Kurz is an Associate Professor in the Department of Physiology & Pharmacology, Director of the O’Brien Centre for the Bachelor of Health Sciences program and the Associate Dean (Undergraduate Health & Science Education) in the Cumming School of Medicine. She obtained her PhD from Queen’s University (Kingston, ON) and undertook post-doctoral training at the University of Colorado Health Sciences Center and the University of Calgary before opening her own lab in Calgary in 2006.
For a cell to grow and divide, its DNA must be accurately copied and equally distributed into daughter cells. Faulty regulation of these processes can lead to genomic instability, the accumulation of mutations and the development of cancer. Our laboratory studies topoisomerase II (topo II), an essential enzyme that has the formidable task of untangling intertwined DNA. Topo II is also the target of a number of widely used anti-cancer chemotherapeutics.
Our research focuses on two areas. 1) We are examining the emerging roles of topo II in DNA damage and repair. 2) We are following upon our identification of salicylate, the primary metabolite of aspirin, as a novel catalytic inhibitor of topo IIα that decreases the cytotoxicity of common chemotherapeutics. We are now exploring the impact of salicylates on treatment efficacy in a breast tumour model.
- Research Associate:
- Zhili Kang